Skip to main content
logo
Armata Pharmaceuticals, Inc. (ARMP)
NYSEAMERICAN: ARMP · Real-Time Price · USD
3.670
+0.080 (2.23%)
Sep 30, 2026, 4:00 PM EDT - Market closed

Armata Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-192.18-173.8-18.92-69.05-36.92-23.16
Depreciation & Amortization
1.841.531.330.970.891.17
Loss (Gain) From Sale of Assets
---0.08--
Asset Writedown & Restructuring Costs
5.415.41----
Stock-Based Compensation
5.722.612.890.943.112.88
Other Operating Activities
154.02139.9-20.7529.28--1.25
Change in Accounts Payable
0.34-0.33-3.760.043.670.18
Change in Other Net Operating Assets
-0.57-1.081.66-9.69-3.23-3.41
Operating Cash Flow
-25.42-25.76-37.55-47.42-32.48-23.58
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.37-0.54-1.88-8.14-2.21-1.3
Sale of Property, Plant & Equipment
---0.01--
Investing Cash Flow
-0.37-0.54-1.88-8.13-2.21-1.3

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-2534.8954.03--
Total Debt Issued
402534.8954.03--
Net Debt Issued (Repaid)
402534.8954.03--
Issuance of Common Stock
4.240.660.130.0144.5226.93
Repurchase of Common Stock
-0.1-0.05-0.06-0.04--
Other Financing Activities
-----0.5-1.41
Financing Cash Flow
44.1525.6134.9653.9944.0225.52

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
18.35-0.69-4.47-1.579.320.64

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-25.79-26.31-39.43-55.57-34.69-24.88
Free Cash Flow Growth
------
Free Cash Flow Margin
-465.34%-536.40%-762.08%-1226.91%-629.85%-556.08%
Free Cash Flow Per Share
-0.71-0.73-0.67-1.54-1.01-1.03
Levered Free Cash Flow
-27.41-26.73-29.4-27.75-24.24-16.82
Unlevered Free Cash Flow
-14.05-16.36-22.69-26.11-24.24-16.78

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Change in Working Capital
-0.23-1.41-2.1-9.650.44-3.22
SEC Filings: 10-K · 10-Q